All Relations between Depression and serotonin

Publication Sentence Publish Date Extraction Date Species
N Klein, J Sacher, T Geiss-Granadia, T Attarbaschi, N Mossaheb, R Lanzenberger, C Pötzi, A Holik, C Spindelegger, S Asenbaum, R Dudczak, J Tauscher, S Kaspe. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. Psychopharmacology. vol 188. issue 3. 2007-03-13. PMID:16955282. escitalopram is a dual serotonin reuptake inhibitor (ssri) approved for the treatment of depression and anxiety disorders. 2007-03-13 2023-08-12 human
Vojtech Hainer, Karolina Kabrnova, Bashar Aldhoon, Marie Kunesova, Martin Wagenknech. Serotonin and norepinephrine reuptake inhibition and eating behavior. Annals of the New York Academy of Sciences. vol 1083. 2007-03-07. PMID:17148744. brain neurotransmitters, serotonin and norepinephrine, play an important role in the central nervous control of energy balance and are involved in symptomatology related to both obesity and depression. 2007-03-07 2023-08-12 human
Vojtech Hainer, Karolina Kabrnova, Bashar Aldhoon, Marie Kunesova, Martin Wagenknech. Serotonin and norepinephrine reuptake inhibition and eating behavior. Annals of the New York Academy of Sciences. vol 1083. 2007-03-07. PMID:17148744. selective serotonin reuptake inhibitors (ssri) have been used in the treatment of depression and eating disorders but have failed to achieve sustained weight loss in the treatment of obesity. 2007-03-07 2023-08-12 human
Grégory Conductier, Nicole Dusticier, Guillaume Lucas, Francine Côté, Guy Debonnel, Annie Daszuta, Aline Dumuis, André Nieoullon, René Hen, Joël Bockaert, Valérie Compa. Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse. The European journal of neuroscience. vol 24. issue 4. 2007-03-06. PMID:16930432. decreased serotonin (5-ht) transmission is thought to underlie several mental diseases, including depression and feeding disorders. 2007-03-06 2023-08-12 mouse
Vikas Kaura, Colin D Ingram, Sarah E Gartside, Allan H Young, Sarah J Judg. The progesterone metabolite allopregnanolone potentiates GABA(A) receptor-mediated inhibition of 5-HT neuronal activity. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 17. issue 2. 2007-03-02. PMID:16574382. this effect on 5-ht neurotransmission may have relevance for mood disorders commonly associated with reproductive hormone events, such as premenstrual dysphoric disorder and postpartum depression. 2007-03-02 2023-08-12 Not clear
Soledad Romero, Luis Pintor, Montserrat Serra, Teresa Plana, Víctor Navarro, Cristóbal Gastó, Benjamin Goldstei. Syndrome of inappropriate secretion of antidiuretic hormone due to citalopram and venlafaxine. General hospital psychiatry. vol 29. issue 1. 2007-03-01. PMID:17189754. selective serotonin reuptake inhibitors (ssris) and venlafaxine are often used to treat depression in the elderly due to their low incidence of side effects. 2007-03-01 2023-08-12 Not clear
T Ito, R Sakakibara, K Nakazawa, T Uchiyama, T Yamamoto, Z Liu, E Shimizu, T Hattor. Effects of electrical stimulation of the raphe area on the micturition reflex in cats. Neuroscience. vol 142. issue 4. 2007-02-27. PMID:16996219. recent evidence has shown that centrally administered serotonin has modulatory effects on micturition function, and that decreased brain serotonin might underlie depression and an overactive bladder. 2007-02-27 2023-08-12 Not clear
Natalia Alenina, Saleh Bashammakh, Michael Bade. Specification and differentiation of serotonergic neurons. Stem cell reviews. vol 2. issue 1. 2007-02-27. PMID:17142880. because serotonin is a relevant pathophysiological factor in several neurological diseases such as bipolar disorder and depression tools to generate or maintain serotonergic neurons might be of therapeutic value. 2007-02-27 2023-08-12 mouse
Joost P van Melle, Peter de Jonge, Maarten P van den Berg, Harm J Pot, Dirk J van Veldhuise. Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors. Drugs. vol 66. issue 16. 2007-02-26. PMID:17112303. treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors. 2007-02-26 2023-08-12 Not clear
Joost P van Melle, Peter de Jonge, Maarten P van den Berg, Harm J Pot, Dirk J van Veldhuise. Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors. Drugs. vol 66. issue 16. 2007-02-26. PMID:17112303. in this review, the literature is evaluated on (i) the antidepressant efficacy of selective serotonin reuptake inhibitors (ssris) for depression in patients with acs; (ii) the pleiomorphic effects of ssris that may be associated with cardiovascular prognosis; and (iii) the effects of ssris on cardiovascular prognosis.ssris provide modest relief of depressive symptoms in selected subgroups of depressed patients with acs. 2007-02-26 2023-08-12 Not clear
Elisabeth Maurer-Spurej, Cheryl Pittendreigh, Shaila Misr. Platelet serotonin levels support depression scores for women with postpartum depression. Journal of psychiatry & neuroscience : JPN. vol 32. issue 1. 2007-02-26. PMID:17245471. platelet serotonin levels support depression scores for women with postpartum depression. 2007-02-26 2023-08-12 Not clear
Elisabeth Maurer-Spurej, Cheryl Pittendreigh, Shaila Misr. Platelet serotonin levels support depression scores for women with postpartum depression. Journal of psychiatry & neuroscience : JPN. vol 32. issue 1. 2007-02-26. PMID:17245471. this study examined whether a new measurement for platelet serotonin could aid in the diagnosis of postpartum depression and support the results from questionnaires. 2007-02-26 2023-08-12 Not clear
N N Dygalo, G T Shishkina, T S Kalinina, A M Yudina, E S Ovchinnikov. Effect of repeated treatment with fluoxetine on tryptophan hydroxylase-2 gene expression in the rat brainstem. Pharmacology, biochemistry, and behavior. vol 85. issue 1. 2007-02-23. PMID:16982082. selective serotonin (5-ht) reuptake inhibitors such as fluoxetine are widely used in the treatment of depression and anxiety; however, the mechanisms underlying their action and particularly the delay in therapeutic onset remain unclear. 2007-02-23 2023-08-12 human
Chittaranjan Andrade, Savita G Bhakta, Nagendra M Sing. Controversy revisited: Selective serotonin reuptake inhibitors in paediatric depression. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 7. issue 4. 2007-02-23. PMID:17071546. controversy revisited: selective serotonin reuptake inhibitors in paediatric depression. 2007-02-23 2023-08-12 human
Chittaranjan Andrade, Savita G Bhakta, Nagendra M Sing. Controversy revisited: Selective serotonin reuptake inhibitors in paediatric depression. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 7. issue 4. 2007-02-23. PMID:17071546. selective serotonin reuptake inhibitors (ssris) are currently controversial treatments for paediatric depression. 2007-02-23 2023-08-12 human
Fady Rachid, Jean Golaz, Guido Bondolfi, Gilles Bertsch. Induction of a mixed depressive episode during rTMS treatment in a patient with refractory major depression. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 7. issue 4. 2007-02-23. PMID:17071547. we report the case of a 39-year-old woman suffering from refractory chronic major depression who developed a depressive mixed episode associated with a mild serotonin syndrome during her second week of rtms treatment. 2007-02-23 2023-08-12 Not clear
Derick E Vergne, Charles B Nemerof. The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression. Current psychiatry reports. vol 8. issue 6. 2007-02-22. PMID:17094925. the interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression. 2007-02-22 2023-08-12 Not clear
Derick E Vergne, Charles B Nemerof. The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression. Current psychiatry reports. vol 8. issue 6. 2007-02-22. PMID:17094925. since the development of the selective serotonin (5-ht) reuptake inhibitors, a putative role for the 5-ht transporter (sert) in the etiology of depression has been explored. 2007-02-22 2023-08-12 Not clear
C Herráiz, G Plaza, J M Aparici. [Mechanisms and management of hyperacusis (decreased sound tolerance)]. Acta otorrinolaringologica espanola. vol 57. issue 8. 2007-02-22. PMID:17117696. the role of the serotonin, also involved in other diseases related with hyperacusis (migraine, depression), can be crucial in this disorder. 2007-02-22 2023-08-12 Not clear
Paul J Goodnic. Bipolar depression: a review of randomised clinical trials. Expert opinion on pharmacotherapy. vol 8. issue 1. 2007-02-22. PMID:17163803. randomised, controlled trials have been completed in the study of the response of bipolar depression to lithium, antiepileptic drugs, antidepressants (particularly the selective serotonin re-uptake inhibitors) and a few miscellaneous agents including pramipexole. 2007-02-22 2023-08-12 Not clear